Highly validated antibody with 1,629 RRID-verified research citations across 108 targets. Confirmed for WB. Reactive in Mouse.

Anti-mouse IgG, HRP-linked Antibody

Cell Signaling TechnologyCat# 7076
1,629citations
Applications
WB
Reactivity
Mouse
HostHorse
ClonalityPolyclonal Secondary
Research Usage1,629citations
View on Cell Signaling TechnologyView RRID verification

More HER2 antibodies from other suppliers

Compared on specifications and validation. No paid placements.

ERBB2 (Ab-1221/1222) Antibody
CUSABIOCat# CSB-PA899547
Validated · ELISA, WB, IHC
Applications
ELISAWBIHCIF
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
ERBB2 (Ab-1248) Antibody
CUSABIOCat# CSB-PA115264
Validated · ELISA, WB, IHC
Applications
ELISAWBIHCIF
Reactivity
HumanMouseRat
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
ERBB2 (Ab-877) Antibody
CUSABIOCat# CSB-PA200841
Validated · ELISA, WB, IHC
Applications
ELISAWBIHC
Reactivity
HumanMouseRat
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
Validated · ELISA
Applications
ELISA
Reactivity
Human
Host
ClonalityMonoclonal
View datasheet on CUSABIO
ERBB2 Antibody
CUSABIOCat# CSB-PA008092
Validated · WB, IHC, ELISA
Applications
WBIHCELISA
Reactivity
HumanMouseRat
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
ERBB2 Antibody
CUSABIOCat# CSB-PA003405
Validated · WB, IHC, ELISA
Applications
WBIHCELISA
Reactivity
HumanMouseRat
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
ERBB2 Antibody
CUSABIOCat# CSB-PA972166
Validated · ELISA, WB
Applications
ELISAWB
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
ERBB2 Antibody
CUSABIOCat# CSB-PA09759A0Rb
Validated · ELISA, IHC
Applications
ELISAIHC
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO

+ 52 more HER2 options from other suppliers.

Compare Cell Signaling Technology 7076 with alternatives

Product verified through the Antibody Registry (RRID). Application and species data from supplier specifications and published research. No paid placements.